On July 21, Oklo rose 5.11% in regular trading, trading at $43.42/share, with turnover of approximately $91.69 million. The rally was driven by a convergence of nuclear power sector tailwinds and company-specific milestones.

On the industry level, the nuclear power supply chain is experiencing a triple resonance of rising fuel prices, capital expansion, and growing demand, lifting the broader sector. At the company level, Oklo's Groves Isotope Test Reactor in Texas has received final documented safety analysis approval from the US Department of Energy. Only two steps remain — readiness review and startup approval — before the facility is authorized to load nuclear fuel and conduct startup testing. The company is targeting first criticality within July.

Supporting the longer-term outlook, Oklo recently signed a letter of intent with Centrus Energy for supply of high-assay low-enriched uranium to power up to five Aurora powerhouses, with deliveries starting in 2029. The DOE also approved the preliminary documented safety analysis for Oklo's Aurora powerhouse at Idaho National Laboratory in June, further de-risking the commercial deployment pathway.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)